National Comprehensive Cancer Network

|
|
|
|
For Patients

About NCCN

Hodgkin Disease/Lymphoma Panel

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Ranjana H. Advani, MD

Eisai Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Allos;
Seattle Genetics;
Pharmacyclics

Seattle Genetics

None

None

11/20/2009

Weiyun Z. Ai, MD

None

None

None

None

7/23/2009

Richard F. Ambinder, MD, PhD

Genentech, Inc.

None

None

None

1/2/2009

Philip J. Bierman, MD

Bradmer Pharmaceuticals

None

None

None

9/18/2009

Kristie A. Blum, MD

None

None

None

None

7/1/2009

Bouthaina Dabaja, MD

None

None

None

None

7/6/2009

Benjamin Djulbegovic, MD, PhD

Millennium Pharmaceuticals, Inc.

None

None

None

9/29/2009

Ysabel Duron

       

Pending

Andrew M. Evens, DO, MS

None

None

None

None

7/1/2009

Andres Forero, MD

Biogen Idec;
Daiichi- Sankyo Co.;
Eli Lilly and Company;
Genentech, Inc.;
BioCryst;
Immunomedics;
Seattle Genetics

None

None

None

9/28/2009

Lauren Gallagher, PhD

None

None

None

None

8/28/2009

Leo I. Gordon, MD

CureTech Ltd.;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Pharmacyclics

CureTech Ltd.

None

CureTech Ltd.

7/21/2009

Kristina M Gregory, RN, MSN, OCN

None

None

None

None

8/21/2009

Francisco Hernandez-Ilizaliturri, MD

None

None

None

None

7/6/2009

Ephraim P. Hochberg, MD

None

Amgen Inc.;
Biogen Idec;
Enzon Pharmaceuticals;
Genentech, Inc.

None

None

7/22/2009

Richard T. Hoppe, MD

None

None

None

None

7/22/2009

Melissa M. Hudson, MD

None

None

None

None

7/3/2009

Mark S. Kaminski, MD

Cephalon, Inc.;
Genzyme Corporation;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation

GlaxoSmithKline

GlaxoSmithKline

None

11/20/2009

David G. Maloney, MD, PhD

None

Genentech, Inc.

None

None

11/20/2009

David Mansur, MD

None

None

None

None

7/10/2009

Peter Mauch, MD

None

None

None

None

11/20/2009

Joan S McClure, MS

None

None

None

None

9/28/2009

Joseph O. Moore, MD

Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

10/28/2009

David Morgan, MD

None

None

None

None

10/6/2009

Craig H. Moskowitz, MD

Cephalon, Inc.;
Eli Lilly and Company;
Medarex, Inc.;
Seattle Genetics

Seattle Genetics

None

None

7/1/2009

Russell J. Schilder, MD

None

None

None

None

7/2/2009

Hema Sundar, PhD

None

None

None

Cephalon, Inc.

12/15/2008

Lawrence Weiss, MD

Clarient, Inc

Clarient, Inc

Clarient, Inc

Clarient, Inc

11/20/2009

Jane N. Winter, MD

Genentech, Inc.

None

None

None

11/20/2009

Joachim Yahalom, MD

None

None

None

None

11/20/2009

 

NCCN Website Supporters